Forward Pharma A/S Income Tax Expense Continuing Operations
Forward Pharma A/S reported Income Tax Expense Continuing Operations of -$204.00 thousand for the 12-month period ending 2018-12-31, per its 20-F filed 2021-04-14.
Discontinued › Expense Statement › Income Tax
ifrs-full:IncomeTaxExpenseContinuingOperations · last filed 2021-04-14
| Period end | Income Tax Expense Continuing Operations 6 month | Income Tax Expense Continuing Operations 12 month |
|---|---|---|
| 2018-12-31 | -$204.00K 20-F · filed 2021-04-14 | |
| 2018-06-30 | -$204.00K 6-K · filed 2018-09-19 | |
| 2017-12-31 | $267.39M 20-F · filed 2020-04-24 | |
| 2017-06-30 | $271.77M 6-K · filed 2018-09-19 | |
| 2016-12-31 | -$21.20M 20-F · filed 2019-04-04 | |
| 2015-12-31 | -$336.00K 20-F · filed 2018-04-30 |